Background: There is currently no strong evidence for a linkage between glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer disease (AD). Results: GAPDH aggregates enhanced amyloid- peptide (A) amyloidogenesis and augmented A40-induced neurotoxicity, both in vitro and in vivo, concomitant with mitochondrial dysfunction. Conclusion: GAPDH aggregates accelerate A amyloidogenesis. Significance: A amyloidogenesis associated with GAPDH aggregation might underlie AD pathogenesis.